// company-profile
Kalaris Therapeutics, Inc.
KLRSExchange: NasdaqSector: Biological Products, (No Diagnostic Substances)Inc.: DEFilings: 119Insiders: 24
// activity-summary
No insider transactions in the last 30 days.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 20, 2026 | Hagen Brett R | KLRS | Sale | 1,915 | $6.72 | $13K |
| Mar 19, 2026 | Oxtoby Andrew | KLRS | Award | 222,000 | $0.00 | $0K |
| Mar 19, 2026 | Feinsod Matthew | KLRS | Award | 135,000 | $0.00 | $0K |
| Mar 19, 2026 | Hagen Brett R | KLRS | Award | 60,800 | $0.00 | $0K |
| Mar 19, 2026 | Gall Matthew | KLRS | Award | 95,000 | $0.00 | $0K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →